| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.41B | -47.3% |
| Gross profit | ¥0.07B | — |
| Operating income | ¥0.03B | — |
| Net income | ¥0.03B | +6.6% |
| Gross margin | 18.3% | Net margin 7.2% |
| Revenue Q/Q | -37.1% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.33B | 81.7% |
| R&D | ¥0.04B | 9.0% |
| SG&A | ¥0.04B | 9.1% |
| Tax & other | ¥0.00B | 0.7% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
达刚控股 ・ 龙源技术 ・ 西部牧业 ・ 建新股份 ・ 新开源 ・ 华仁药业 ・ 向日葵 ・ 万讯自控 ・ 顺网科技 ・ 长盈精密 ・ 东方日升 ・ 瑞普生物
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies